The Hindu Business Line : Goldman Sachs ups stake in Strides

GOLDMAN Sachs Investments (Mauritius) I Ltd has raised its stake in Strides Arcolab Ltd by acquiring 85,200 shares or 0.24 per cent of the share capital of the Bangalore-based pharma company.

The shares were bought from the market on February 14. (The scrip closed at Rs 391.3 on Nifty on that day.)

Post-purchase, the FII holds 24,86,047 shares aggregating to 7.11 per cent of the company's share capital, according to the company's intimation to the Bombay Stock Exchange.

The generic drugs and nutraceuticals exporter closed the fiscal year ended December 31, 2005 with a revenue of Rs 333.8 crore and net profit of Rs 46.1 crore for its Indian operations.

More Stories on : Foreign Institutional Investors | Pharmaceuticals

Article E-Mail :: Comment :: Syndication :: Printer Friendly Page

Stories in this Section
Idbipaisabuilder launched in Kochi

Heavyweights drive Sensex to new high

Heritage Foods firm on retailing, construction plans

Reliance Energy Ventures listing tomorrow

Sideways movement

Artson Engg: To change hands?

GE Shipping, Mercator Lines buoyant

`More global investors entering India'
Deutsche Bank upbeat

Goldman Sachs ups stake in Strides

Manage risks with large-cap exposure: JP Morgan

Capital goods, metals & pharma hog limelight

IPO scam fall-out — CBI conducts search at Karvy, Vijaya Bank, BhOB premises

KNR Constructions to raise Rs 160 crore

NSDL, CDSL told to update bank details of account holders

Inox IPO price is Rs 120

Union Bank offer price fixed at Rs 110 — Issue subscribed 30 times